I agree that this site is using cookies. You can find further informations here.
X
Moretto, Roberto
141  results:
OpenAccess-fulltext X
Search for persons X
?
1

Immune-related pan-cancer gene expression signatures of pat..:

D'Angelo, Alberto ; Kilili, Huseyin ; Chapman, Robert...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9844904/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
2

Dissecting tumor lymphocyte infiltration to predict benefit..:

Moretto, Roberto ; Rossini, Daniele ; Catteau, Aurélie...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10124320/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
3

Exploring the Outcome of Disappearance or Small Remnants of..:

Boraschi, Piero ; Moretto, Roberto ; Donati, Francescamaria...
info:eu-repo/semantics/altIdentifier/pmid/37190129.  , 2023
Link: https://hdl.handle.net/1..
 
?
4

Exploring the Outcome of Disappearance or Small Remnants of..:

Boraschi, Piero ; Moretto, Roberto ; Donati, Francescamaria...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10137163/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
5

Safety and Activity of PolyPEPI1018 Combined with Maintenan..:

Hubbard, Joleen M ; Tőke, Enikő R ; Moretto, Roberto...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9365360/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
6

Upfront Modified Fluorouracil, Leucovorin, Oxaliplatin, and..:

Rossini, Daniele ; Antoniotti, Carlotta ; Lonardi, Sara...
info:eu-repo/semantics/altIdentifier/pmid/35666229.  , 2022
Link: https://hdl.handle.net/1..
 
?
7

Surgery combined with intra-operative microwaves ablation f..:

Guadagni, Simone ; Marmorino, Federica ; Furbetta, Niccolò...
info:eu-repo/semantics/altIdentifier/pmid/36505851.  , 2022
Link: https://hdl.handle.net/1..
 
?
8

Upfront Modified Fluorouracil, Leucovorin, Oxaliplatin, and..:

Rossini, Daniele ; Antoniotti, Carlotta ; Lonardi, Sara...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426812/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
9

Surgery combined with intra-operative microwaves ablation f..:

Guadagni, Simone ; Marmorino, Federica ; Furbetta, Niccolò...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9731276/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
10

Immune Checkpoint Inhibitors in Mismatch Repair Proficient/..:

Germani, Marco Maria ; Moretto, Roberto
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750658/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
11

CEA increase as a marker of disease progression after first..:

Moretto, Roberto ; Rossini, Daniele ; Conca, Veronica...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437964/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
12

AtezoTRIBE: a randomised phase II study of FOLFOXIRI plus b..:

Antoniotti, Carlotta ; Borelli, Beatrice ; Rossini, Daniele...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376656/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
13

Upfront FOLFOXIRI plus bevacizumab and reintroduction after..:

Cremolini, Chiara ; Antoniotti, Carlotta ; Rossini, Daniele...
info:eu-repo/semantics/altIdentifier/pmid/32164906.  , 2020
Link: https://hdl.handle.net/2..
 
?
14

The Pan-Immune-Inflammation Value is a new prognostic bioma..:

Fucà, Giovanni ; Guarini, Vincenzo ; Antoniotti, Carlotta...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403416/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
15

Treatments after progression to first-line FOLFOXIRI and be..:

Rossini, Daniele ; Lonardi, Sara ; Antoniotti, Carlotta...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7782547/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
1-15